Therefore, resveratrol’s ability to modulate JAK-STAT signaling, especially through STAT3 inactivation, highlights its potential as a therapeutic agent in combination with TMZ for treating glioblastoma, potentially overcoming chemoresistance and improving patient outcomes. This evidence concerns the gene SOAT1 and glioblastoma.